--Myriad Genetics, Inc., a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer, effective May 1, 2025.

BENTONVILLE, Ark. — People from across the country traveled to Crystal Bridges for the opening of its new exhibit. The exhibit is known as "KAWS." It's the stage name of artist Brian Donnelly.

"KAWS: FAMILY" sponsors caught a preview of the latest temporary exhibition and had a chance to visit with artist Brian Donnelly, better known as KAWS, on March 13 at Crystal Bridges Museum of ...

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian ...

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian ...